The latest announcement is out from Biofrontera (BFRI).
At the Company’s Annual Meeting, stockholders cast their votes on several key issues. John J. Borer III, JD, and Prof. Hermann Luebbert, Ph.D., were elected as Class III directors, with significant majority support. Additionally, an amendment was approved to increase the number of shares authorized for issuance significantly. Furthermore, Marcum LLP was ratified as the Company’s independent auditor for the upcoming fiscal year, again with overwhelming stockholder support. These decisions are crucial as they shape the company’s governance and strategic financial planning.
For an in-depth examination of BFRI stock, go to TipRanks’ Stock Analysis page.
